SILO PHARMA, INC. Other Commitment, to be Paid, Remainder of Fiscal Year
SILO PHARMA, INC. (SILO) had Other Commitment, to be Paid, Remainder of Fiscal Year of $1.25 million as of 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Notes › Other Commitments
us-gaap:OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear · last filed 2025-08-13
- 2025-06-30: Other Commitment, to be Paid, Remainder of Fiscal Year $1.25M.
- 2025-03-31: Other Commitment, to be Paid, Remainder of Fiscal Year $1.57M.
| Period end | Other Commitment, to be Paid, Remainder of Fiscal Year |
|---|---|
| 2025-06-30 | $1.25M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $1.57M 10-Q · filed 2025-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |